Drugs / sodium DNA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07376148 | Nov 2025 → Feb 2026 overdue | skin disorder | Instituto de Oftalmología Fundación Conde de Valenciana | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium DNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07376148 ↗ |
| Route | Topical | “topical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment” NCT07376148 ↗ |